# Yugong Biotechnology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/yugong-biotechnology

- Industry: Biotechnology
- Headquarters: Lianyungang, China
- Latest round: Series A (Feb 2, 2023)
- Investors on record: 2

## About

Based in Lianyunganag, China, and founded in 2021, Yugong Biotechnology operates as a nucleic acid raw material manufacturer, committed to providing tools, enzymes and raw materials for China's biomedical industry. The company has built a 4500 square meters of R & D, production base, including a 500 square meters of clean production workshop. Yugong Biotechnology has set up a subsidiary.

The company is engaged in molecular diagnosis and nucleic acid drug production raw material enzymes, life science tool enzymes and related reagents research and development and production. Yugong Biotechnology has more than 100 kinds of terminal products in 10 series, including restriction enzyme, PCR, isothermal amplification, reverse transcription, fluorescence quantitative PCR, in vitro transcription, modified cloning, and buffer solution instant granules.

## Funding rounds

- Series A, Feb 2, 2023 — Addor Capital
- Angel, Jan 28, 2023 — Jiangsu Jinqiao Private Equity Fund Management

## Investors

- Jiangsu Jinqiao Private Equity Fund Management (https://capitalatlas.ai/funds/jiangsu-jinqiao-private-equity-fund-management) — Angel
- Addor Capital (https://capitalatlas.ai/funds/addor-capital) — Series A